Surgical management of the cases with both biliary and duodenal obstruction

다국어 초록 (Multilingual Abstract)

Endoscopic management is presently the recommended first-line of treatment for biliary strictures. However, surgery still has an important role especially for biliary obstruction (BO) with duodenal obstruction. Even though endoscopic treatment for concurrent BO and gastric-outlet obstruction has been proposed, it is still not widespread. Duodenal obstruction is often associated with malignant BO which makes endoscopic treatment more challenging. Biliary and gastrointestinal double bypass with Roux-en-Y hepaticojejunostomy and gastrojejunostomy is the most common surgical intervention for malignant biliary and gastric-outlet obstruction. A variety of procedures of biliary bypass and gastrointestinal bypass have been reported. According to several studies, mortality rates range from 0% to 7%, while morbidity rates range from 3% to 50%. Higher morbidity was observed in symptomatic patients caused by the disease. Most common morbidity after double bypass was delayed gastric emptying. Recurrence of BO and gastric-outlet obstruction was less frequently seen after surgical bypass compared to after endoscopic treatment. Minimally invasive approach has been applied to double bypass. Studies showed that laparoscopic double bypass has a shorter hospital stay and reduced postoperative pain; however, due to its technical demand, it is still presently an uncommon procedure. Robotic bypass surgery may resolve this issue in the future. Further analyses of outcomes of both surgical and endoscopic treatments are necessary to establish better and suitable palliation options for concurrent biliary and duodenal obstruction caused by unresectable malignant tumors.

참고문헌 (Reference)

1 Van Heek NT, "The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life" 238 : 894-902, 2003

2 Kaminishi M, "Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma" 132 : 184-187, 1997

3 Jeurnink SM, "Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction : a systematic review" 7 : 18-, 2007

4 Toumi Z, "Role of the laparoscopic approach to biliary bypass for benign and malignant biliary diseases : a systematic review" 25 : 2105-2116, 2011

5 Lai EC, "Robot-assisted laparoscopic hepaticojejunostomy for advanced malignant biliary obstruction" 38 : 210-213, 2015

6 Miyasaka Y, "Prophylactic biliary and gastrointestinal bypass for unresectable pancreatic head cancer : a retrospective case series" 18 : 470-474, 2017

7 Insulander J, "Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma" 103 : 1200-1208, 2016

8 Miyasaka Y, "Pioneers in laparoscopic hepatobiliary-pancreatic surgery" 25 : 109-111, 2018

9 Tempero MA, "Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology" 15 : 1028-1061, 2017

10 Lesurtel M, "Palliative surgery for unresectable pancreatic and periampullary cancer : a reappraisal" 10 : 286-291, 2006

11 Walter J, "Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head" 37 : 798-804, 2011

12 Fusai G, "Outcome of R1 resection in patients undergoing pancreatico-duodenectomy for pancreatic cancer" 34 : 1309-1315, 2008

13 Lyons JM, "Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days" 14 : 469-475, 2012

14 Koga A, "One stage hepaticocholecystojejunostomy as an easy and long term effective bilioenteric bypass for unresectable carcinoma of the pancreas" 165 : 177-179, 1987

15 Tol JA, "Non-radical resection versus bypass procedure for pancreatic cancer : a consecutive series and systematic review" 41 : 220-227, 2015

16 Mizuguchi Y, "Modified laparoscopic biliary enteric anastomosis procedure using handmade double-armed needles" 9 : 93-96, 2016

17 Moss AC, "Malignant distal biliary obstruction : a systematic review and meta-analysis of endoscopic and surgical bypass results" 33 : 213-221, 2007

18 Shimi S, "Laparoscopy in the management of pancreatic cancer : endoscopic cholecystojejunostomy for advanced disease" 79 : 317-319, 1992

19 Wilson RG, "Laparoscopic gastroenterostomy for malignant duodenal obstruction" 79 : 1348-, 1992

20 Röthlin MA, "Laparoscopic gastro-and hepaticojejunostomy for palliation of pancreatic cancer : a case controlled study" 13 : 1065-1069, 1999

21 Rhodes M, "Laparoscopic biliary and gastric bypass : a useful adjunct in the treatment of carcinoma of the pancreas" 36 : 778-780, 1995

22 Lillemoe KD, "Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial" 230 : 322-328, 1999

23 Hamada T, "International study of endoscopic management of distal malignant biliary obstruction combined with duodenal obstruction" 53 : 46-55, 2018

24 Ueda J, "Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer" 61 : 197-202, 2014

25 Nakai Y, "Endoscopic management of combined malignant biliary and gastric outlet obstruction" 29 : 16-25, 2017

26 Brewer Gutierrez OI, "Double endoscopic bypass for gastric outlet obstruction and biliary obstruction" 5 : E893-E899, 2017

27 Ausania F, "Double bypass for inoperable pancreatic malignancy at laparotomy : postoperative complications and long-term outcome" 94 : 563-568, 2012

28 Bockhorn M, "Crossing the rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of “desmoplastic pseudo-pancreatitis” and anatomical site of irresectability" 16 : 1212-1221, 2009

29 Räty S, "Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer : patientand disease-related risk factors" 53 : 133-137, 2006

30 Mann CD, "Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease" 79 : 471-475, 2009

31 Schniewind B, "Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses" 13 : 1403-1411, 2006

32 Heinicke JM, "Bilio-digestive double bypass for nonresectable pancreatic cancer" 19 : 165-167, 2002

33 Kumagai K, "A systematic review and meta-analysis comparing partial stomach partitioning gastrojejunostomy versus conventional gastrojejunostomy for malignant gastroduodenal obstruction" 401 : 777-785, 2016

34 Glazer ES, "A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction" 47 : 307-314, 2014